Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



Watson Said to Near $6.6 Billion Deal for Actavis

Watson Pharmaceuticals is expected to bid as much as €5 billion ($6.6 billion) for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers.
read more

share

Copyright © 2011 Regator, LLC